Circulating DNA and Lung Cancer
Authors:
- 5 September 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1075 (1) , 154-164
Abstract
Lung cancer is the leading cause of cancer death worldwide. The majority of patients is diagnosed too late for curative treatment. There is an urgent need for a noninvasive test to identify early lung cancer. Although levels of circulating cell‐free DNA in plasma or serum are higher in patients with lung cancer than in healthy controls, it is not yet clear whether this will be of diagnostic or prognostic significance. The finding that circulating DNA in lung cancer patients exhibits genetic and epigenetic changes typical of the tumor (including chromosome loss, oncogene activation, and tumor‐suppressor gene inactivation by methylation) has led to intense efforts to determine whether these are sensitive and specific enough to be used clinically. Here we review the evidence on circulating DNA in lung cancer and consider possible future applications in patient management.Keywords
This publication has 22 references indexed in Scilit:
- P-752 Biomarkers for small cell lung cancer (SCLC): DNA methylationand GD2 synthase transcript levelsLung Cancer, 2005
- PD-026 The analysis of serum DNA concentration by means of hTERT quantification: A useful prognostic factor in advanced non-small cell lung cancer (NSCLC)Lung Cancer, 2005
- O-044 Storage of plasma or isolated plasma DNA affects the results ofcirculating DNA quantification assaysLung Cancer, 2005
- Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing ChemotherapyJournal of Clinical Oncology, 2004
- Circulating Nucleosomes Predict the Response to Chemotherapy in Patients with Advanced Non–Small Cell Lung CancerClinical Cancer Research, 2004
- Amount of DNA in plasma and cancer risk: A prospective studyInternational Journal of Cancer, 2004
- Quantification of Free Circulating DNA As a Diagnostic Marker in Lung CancerJournal of Clinical Oncology, 2003
- Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patientsInternational Journal of Cancer, 2003
- Nucleosomes in serum of patients with benign and malignant diseasesInternational Journal of Cancer, 2001
- Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumoursCancer Letters, 1995